vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and Enhabit, Inc. (EHAB). Click either name above to swap in a different company.
ALBANY INTERNATIONAL CORP is the larger business by last-quarter revenue ($321.2M vs $270.4M, roughly 1.2× Enhabit, Inc.). ALBANY INTERNATIONAL CORP runs the higher net margin — 4.3% vs -14.3%, a 18.6% gap on every dollar of revenue. On growth, ALBANY INTERNATIONAL CORP posted the faster year-over-year revenue change (12.0% vs 4.7%). ALBANY INTERNATIONAL CORP produced more free cash flow last quarter ($51.4M vs $3.3M). Over the past eight quarters, Enhabit, Inc.'s revenue compounded faster (1.5% CAGR vs 1.2%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
AIN vs EHAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $270.4M |
| Net Profit | $13.9M | $-38.7M |
| Gross Margin | 31.1% | — |
| Operating Margin | 9.3% | -12.3% |
| Net Margin | 4.3% | -14.3% |
| Revenue YoY | 12.0% | 4.7% |
| Net Profit YoY | -21.5% | 15.9% |
| EPS (diluted) | $0.56 | $-0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $270.4M | ||
| Q3 25 | $261.4M | $263.6M | ||
| Q2 25 | $311.4M | $266.1M | ||
| Q1 25 | $288.8M | $259.9M | ||
| Q4 24 | $286.9M | $258.2M | ||
| Q3 24 | $298.4M | $253.6M | ||
| Q2 24 | $332.0M | $260.6M | ||
| Q1 24 | $313.3M | $262.4M |
| Q4 25 | $13.9M | $-38.7M | ||
| Q3 25 | $-97.8M | $11.1M | ||
| Q2 25 | $9.2M | $5.2M | ||
| Q1 25 | $17.4M | $17.8M | ||
| Q4 24 | $17.7M | $-46.0M | ||
| Q3 24 | $18.0M | $-110.2M | ||
| Q2 24 | $24.6M | $-200.0K | ||
| Q1 24 | $27.3M | $200.0K |
| Q4 25 | 31.1% | — | ||
| Q3 25 | -19.1% | — | ||
| Q2 25 | 31.3% | — | ||
| Q1 25 | 33.4% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 33.9% | — | ||
| Q1 24 | 34.7% | — |
| Q4 25 | 9.3% | -12.3% | ||
| Q3 25 | -44.6% | 6.4% | ||
| Q2 25 | 7.2% | 6.3% | ||
| Q1 25 | 9.8% | 6.1% | ||
| Q4 24 | 8.5% | -16.0% | ||
| Q3 24 | 8.4% | -38.6% | ||
| Q2 24 | 12.9% | 4.3% | ||
| Q1 24 | 12.4% | 4.9% |
| Q4 25 | 4.3% | -14.3% | ||
| Q3 25 | -37.4% | 4.2% | ||
| Q2 25 | 2.9% | 2.0% | ||
| Q1 25 | 6.0% | 6.8% | ||
| Q4 24 | 6.2% | -17.8% | ||
| Q3 24 | 6.0% | -43.5% | ||
| Q2 24 | 7.4% | -0.1% | ||
| Q1 24 | 8.7% | 0.1% |
| Q4 25 | $0.56 | $-0.76 | ||
| Q3 25 | $-3.37 | $0.22 | ||
| Q2 25 | $0.31 | $0.10 | ||
| Q1 25 | $0.56 | $0.35 | ||
| Q4 24 | $0.57 | $-0.92 | ||
| Q3 24 | $0.57 | $-2.20 | ||
| Q2 24 | $0.79 | $0.00 | ||
| Q1 24 | $0.87 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $43.6M |
| Total DebtLower is stronger | $455.7M | $426.0M |
| Stockholders' EquityBook value | $726.2M | $534.0M |
| Total Assets | $1.7B | $1.2B |
| Debt / EquityLower = less leverage | 0.63× | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $43.6M | ||
| Q3 25 | $108.3M | $56.9M | ||
| Q2 25 | $106.7M | $37.1M | ||
| Q1 25 | $119.4M | $39.5M | ||
| Q4 24 | $115.3M | $28.4M | ||
| Q3 24 | $127.2M | $45.7M | ||
| Q2 24 | $116.4M | $28.5M | ||
| Q1 24 | $125.4M | $36.5M |
| Q4 25 | $455.7M | $426.0M | ||
| Q3 25 | $480.6M | $441.5M | ||
| Q2 25 | $444.7M | $456.9M | ||
| Q1 25 | $416.4M | $467.3M | ||
| Q4 24 | $318.5M | $492.6M | ||
| Q3 24 | $362.2M | $502.9M | ||
| Q2 24 | $377.1M | $512.7M | ||
| Q1 24 | $439.1M | $526.7M |
| Q4 25 | $726.2M | $534.0M | ||
| Q3 25 | $739.3M | $566.8M | ||
| Q2 25 | $888.6M | $552.4M | ||
| Q1 25 | $900.0M | $543.2M | ||
| Q4 24 | $943.5M | $523.5M | ||
| Q3 24 | $991.0M | $566.1M | ||
| Q2 24 | $967.5M | $674.3M | ||
| Q1 24 | $967.5M | $672.3M |
| Q4 25 | $1.7B | $1.2B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.7B | $1.2B | ||
| Q4 24 | $1.6B | $1.2B | ||
| Q3 24 | $1.8B | $1.3B | ||
| Q2 24 | $1.8B | $1.4B | ||
| Q1 24 | $1.8B | $1.4B |
| Q4 25 | 0.63× | 0.80× | ||
| Q3 25 | 0.65× | 0.78× | ||
| Q2 25 | 0.50× | 0.83× | ||
| Q1 25 | 0.46× | 0.86× | ||
| Q4 24 | 0.34× | 0.94× | ||
| Q3 24 | 0.37× | 0.89× | ||
| Q2 24 | 0.39× | 0.76× | ||
| Q1 24 | 0.45× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | $4.4M |
| Free Cash FlowOCF − Capex | $51.4M | $3.3M |
| FCF MarginFCF / Revenue | 16.0% | 1.2% |
| Capex IntensityCapex / Revenue | 6.9% | 0.4% |
| Cash ConversionOCF / Net Profit | 5.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | $65.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | $4.4M | ||
| Q3 25 | $43.9M | $37.8M | ||
| Q2 25 | $32.7M | $10.6M | ||
| Q1 25 | $2.1M | $17.9M | ||
| Q4 24 | $78.5M | $-4.1M | ||
| Q3 24 | $47.0M | $28.4M | ||
| Q2 24 | $83.4M | $9.6M | ||
| Q1 24 | $9.6M | $17.3M |
| Q4 25 | $51.4M | $3.3M | ||
| Q3 25 | $25.9M | $36.2M | ||
| Q2 25 | $18.8M | $8.7M | ||
| Q1 25 | $-13.5M | $17.6M | ||
| Q4 24 | $60.2M | $-4.7M | ||
| Q3 24 | $31.6M | $27.7M | ||
| Q2 24 | $63.6M | $8.9M | ||
| Q1 24 | $-17.3M | $15.5M |
| Q4 25 | 16.0% | 1.2% | ||
| Q3 25 | 9.9% | 13.7% | ||
| Q2 25 | 6.0% | 3.3% | ||
| Q1 25 | -4.7% | 6.8% | ||
| Q4 24 | 21.0% | -1.8% | ||
| Q3 24 | 10.6% | 10.9% | ||
| Q2 24 | 19.2% | 3.4% | ||
| Q1 24 | -5.5% | 5.9% |
| Q4 25 | 6.9% | 0.4% | ||
| Q3 25 | 6.9% | 0.6% | ||
| Q2 25 | 4.5% | 0.7% | ||
| Q1 25 | 5.4% | 0.1% | ||
| Q4 24 | 6.4% | 0.2% | ||
| Q3 24 | 5.2% | 0.3% | ||
| Q2 24 | 6.0% | 0.3% | ||
| Q1 24 | 8.6% | 0.7% |
| Q4 25 | 5.31× | — | ||
| Q3 25 | — | 3.41× | ||
| Q2 25 | 3.56× | 2.04× | ||
| Q1 25 | 0.12× | 1.01× | ||
| Q4 24 | 4.44× | — | ||
| Q3 24 | 2.61× | — | ||
| Q2 24 | 3.39× | — | ||
| Q1 24 | 0.35× | 86.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
